norfenfluramine has been researched along with mdl 100907 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fink, GD; Li, MW; Ni, W; Thakali, K; Watts, SW | 1 |
Cadiz, EM; Kenney, J; Kwiatkowski, V; Robertson, KL; Rowland, NE | 1 |
2 other study(ies) available for norfenfluramine and mdl 100907
Article | Year |
---|---|
The fenfluramine metabolite (+)-norfenfluramine is vasoactive.
Topics: Animals; Aorta; Blood Pressure; Ergolines; Fenfluramine; In Vitro Techniques; Ketanserin; Male; Norfenfluramine; Prazosin; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Adrenergic, alpha; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Sympathectomy; Sympathetic Nervous System; Vasoconstriction | 2004 |
Action of a serotonergic anorectic in meal-fed mice working for food.
Topics: Animals; Appetite Depressants; Behavior, Animal; Conditioning, Operant; Dose-Response Relationship, Drug; Energy Intake; Feeding Behavior; Injections, Subcutaneous; Male; Meals; Mice; Mice, Inbred ICR; Nerve Tissue Proteins; Neurons; Norfenfluramine; Receptor, Serotonin, 5-HT2C; Reward; Satiety Response; Serotonin 5-HT2 Receptor Antagonists; Time Factors | 2012 |